IM Cannabis
IMCC • NASDAQ
IM Cannabis is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Oren Shuster, with a market cap of $3.0M.
CEOOren Shuster
Next Earnings
Upcoming earnings announcement for IM Cannabis
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 12 earnings reports for IM Cannabis
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q4 2025 | -$0.86 | — | $11.2M | — | — |
| Nov 13, 2025 | Q3 2025 | -$0.54 | — | $10.1M | — | — |
| Aug 12, 2025 | Q2 2025 | -$0.07 | — | $9.2M | — | — |
| May 15, 2025 | Q1 2025 | $0.06 | — | $8.7M | — | — |
| Mar 31, 2025 | Q4 2024 | -$0.23Est: -$0.39 | +41.0% | $9.5MEst: $10.4M | -8.6% | — |
| Nov 14, 2024 | Q3 2024 | -$0.30Est: -$1.41 | +78.7% | $10.2MEst: $15.6M | -34.8% | — |
| Aug 14, 2024 | Q2 2024 | -$0.17Est: -$0.85 | +80.0% | $10.8MEst: $9.6M | +12.7% | — |
| May 8, 2024 | Q1 2024 | -$1.86Est: -$1.20 | -55.0% | $8.9MEst: $10.6M | -15.6% | — |
| Mar 28, 2024 | Q4 2023 | -$1.08Est: -$1.02 | -5.9% | $7.9MEst: $10.5M | -24.8% | — |
| Nov 13, 2023 | Q3 2023 | -$0.72Est: -$1.26 | +42.9% | $9.2MEst: $13.3M | -30.7% | — |
| Aug 14, 2023 | Q2 2023 | -$1.14Est: -$0.42 | -171.4% | $9.8MEst: $13.4M | -26.9% | — |
| May 15, 2023 | Q1 2023 | $0.12Est: -$1.68 | +107.1% | $9.7MEst: $13.8M | -29.4% | — |